Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Can a daily antioxidant supplement help brain artery health after menopause?

Opening soon · Colorado State University

What this means

This trial plans to test whether taking MitoQ daily for 3 months helps brain arteries work better. It has not started recruiting, and no results have been posted yet.

Plain-English summary written by an AI model from the registry listing.

Status
Opening soon
Who can join
Ages 60 and over
Where
1 site, including Colorado

Contacts and how to join ↗

The science

Registered title
Oral Antioxidant Therapy Targeted to the Mitochondria for Improving Brain Artery Health in Postmenopausal Women
Phase
Not applicable
Study type
interventional
Conditions
Aging, Postmenopause
What is tested
Mitoquinone (MitoQ), Placebo
Sponsor
Colorado State University
Ages
60 Years to no maximum
Dates
First posted Feb 12, 2026 · updated Feb 12, 2026

Registry summary

The goal of this clinical trial is to learn if 3 months of taking the dietary supplement MitoQ [a mitochondria-targeted antioxidant that targets to reduce mitochondrial reactive oxygen species (mitoROS)] works to treat age- and menopause-related reductions in brain artery (cerebrovascular) function in postmenopausal women 60 years of age or older free of clinical disease. The main questions it aims to answer are:

Does MitoQ improve cerebrovascular function in postmenopausal women?

If so, does MitoQ improve cerebrovascular function by lowering mitoROS in these arteries?

Researchers will compare MitoQ to a placebo (a look-alike substance that contains no drug) to see if MitoQ can improve cerebrovascular function by lowering mitoROS in arteries involved in brain health and function.

Participants will:

Take MitoQ (20 mg/day) or a placebo every day for 3 months

Visit the research laboratory at baseline and then after 3 months for cerebrovascular testing; there is also a check-in visit at 6 weeks, which is the halfway point

Keep track of symptoms and events during their treatment period to report to the study team

Sites (1)

  • Translational Physiology Laboratory within the Food Science Clinical Research Laboratory, Fort Collins, Colorado, United States

More aging trials in these states

Colorado

Report a problem